ROYCE & ASSOCIATES LP - LEXICON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$2,657,000
+3.8%
2,813,8330.0%0.01%
+11.1%
Q4 2014$2,560,000
-33.6%
2,813,833
+2.8%
0.01%
-30.8%
Q3 2014$3,858,000
-17.0%
2,736,133
-5.2%
0.01%
-7.1%
Q2 2014$4,647,000
-36.6%
2,886,133
-31.8%
0.01%
-36.4%
Q1 2014$7,325,000
-3.9%
4,233,9330.0%0.02%0.0%
Q4 2013$7,621,000
-26.8%
4,233,933
-3.6%
0.02%
-29.0%
Q3 2013$10,414,000
+9.2%
4,393,9330.0%0.03%
+6.9%
Q2 2013$9,535,0004,393,9330.03%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ulys, L.L.C. 29,782,609$47,950,00099.96%
Artal Group S.A. 253,372,135$407,929,00016.49%
NEA Management Company, LLC 11,676,000$18,798,0000.88%
Round Table Services, LLC 151,280$244,0000.20%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 250,000$403,0000.15%
Rhenman & Partners Asset Management AB 294,805$475,0000.14%
WILLIAM HARRIS INVESTORS INC 204,342$329,0000.09%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 2,083,200$3,354,0000.04%
UBS ASSET MANAGEMENT AMERICAS INC 19,478,114$31,360,0000.03%
Teton Advisors, Inc. 235,000$378,0000.02%
View complete list of LEXICON PHARMACEUTICALS INC shareholders